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Novel exploiting to the understanding of conventional medicine was followed by the
findings of many unique secondary metabolites and its biological property and is highly
required for treating of many endemic diseases. The plants have been a long background in
ethno pharmacological knowledge for treatment of endemic and non-endemic diseases.
Such plants are traditionally used in different form of paste, extraction and powder to treat
seasonal diseases. Nowadays main uses of some medicinal plants have been a great deal
with cure and control various chronic diseases such as cancer, AIDS, hepatitis, neurogenic
disorders and acute kidney diseases. Cancer is molecular dysfunction and disarrangement
in DNA base pairs it leads to change the human physiological and biochemical behavior of
the system. Apoptotic mechanisms are regulating by two distinct pathways in which basic
creeds perform in common to all eukaryotes. The key components in apoptosis especially
mitochondrial intracellular organelles are identified (DNA, protein and ATP, Ca2þ). These
components control the next cellular binder step and participate in effecting cell suicide
mechanisms. The diverse aspects of mitochondria involved in apoptosis include dealing
with other proceedings such as release of protein or enzymes to effective for cell death. In
these mechanism plants and related natural products using alternative therapeutic man-
agement, very less toxicity and cost benefits. Plant extracts and its biomass has revealed
the existing of various pharmacologically active compounds like steroids, polyphenols,
polysaccharides, saponins, alkaloids, tannins and terpenoids. The reliable natural products
are acting as high sources for anticancer drugs. The natural derived compounds are the
prolongation of life span of the zeolites and decrease of malignancy cell formation in the
cellular system.
Copyright ª 2013, JPR Solutions; Published by Reed Elsevier India Pvt. Ltd. All rights
reserved.þ60 95492465 (office);
N. Govindan).
2013, JPR Solutions; Publi1. Introduction
The key challenging property and functional behavior of
cancer cells having tremendous secret action in cellular and
functional characteristics. The breaking surreptitious thing ofshed by Reed Elsevier India Pvt. Ltd. All rights reserved.
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scientific community are searching the mechanism of cell
modification, biochemical-molecular pathway changes and
genome expression. A sudden change of single or two more
base pairs in a DNA will leads to form of solid tumor or ma-
lignant deposit. Observably the mechanism of tumor devel-
opment requires advance molecular genomic studies and
therapeutic drug molecules action is needed much more.
Particularly in the malignant tumor are invasive, metastasis,
mutagenic DNA modification, methylation and different
genomic and proteomic expression. These are present in the
major clinical challenges in which treatment of cancer.1,2
Even though the progress that understands of the mecha-
nisms of carcinogen originating to modify the structural and
functional property of DNA. The modern investigation of
tumor by the identification of some biochemical substances,
hormones and enzymes are involved signal transduction
pathways. That compoundmay induce the cellular oncogenes
and suppress/arrest the normal function.3,4 Over the past
decade, there has been an increasing in the demand of drug
development against cancer and related diseases. The plants
have played a vital role in the treatment of chronic and acute
diseases for the very long centuries ago. Nowadays natural
products have been highly focused as an important tool for
drug development and medicinal chemistry for production of
less side effect drugs.5,6 The plant and its derivatives of
chemical compound especially alkaloids, saponins poly-
phenols, terpenoids and tannins natural product studies
suggest that reducing the cancer risk factor with low impact of
side effects.7,8 Plants are mainly used as rapid progress in
prevention and treatment of particularly for the cancers and
related malignant diseases even though have not been
particular site of action and mechanisms, where there is still
strongly green chemistry drugs are needed for more active
remedies.9 Conventional and modern methods are mainly
plant and their products are considered to be one of the pro-
spective sources for the anticancer agents with less adverse
effect. Also other various sources of marine producers such as
fungi, bacteria, seaweeds and algae are produces various
bioactive compounds. That has been considered for their
ability to treat and reduce the risk number of acute diseases
and chronic diseases.10 Plant purified metabolites and its
synthetic nanodrug molecules have been evaluated in clinical
trials and marketed.11,12 On the basis, the present review
focused on the potential of the anticancer effects of plant
based compounds and its molecular behavior of malignant
cell is also being compiled.2. Metastatic behavior of cancer cell line
The tumor cell population or individual cell lines have dif-
ferential accumulation of genetic changes and biochemical
behavior contributes to the reported cases. Phenotype differ-
ences in malignant tumor cells have been well studied in
morphology, development and gene expression of benign and
malignant cells. Cancer cells have a multiple genetic alter-
ations in the molecular dogma, especially the post-transcrip-
tional mechanisms including frequent mutational changes
in p53, caspase genes and miRNA transcriptional factors.Recently human breast cancer characterized its gene struc-
ture to study the metastatic behavior of cancer. The central
part of MUC5B is composed of three alternating domains: i)
the highly conserved domain is called CYS domain ii) a sub-
domain denoted is R domain, it fully made of repetitions and
irregular repeat of 29 amino acid codons, it contains rich in
Ser, Thr and Pro iii) a conserved sub domain has 111 amino
acid it is called as R-end domain also repeated four in four
times, the alternating CYS/R/R end domain build a large
composite repeating unit of 528 amino acids.13 Other impor-
tant findings to examine themain role that NK cells play in the
regulation of metastatic spread of human tumour cells in host
system. The development of tumour metastasis is regulated
by a variety of tumour suppressor genes and/oncogene,
including tumour suppress or gene nm23. The nm23 gene
mainly characterized by its reduced expression of metastatic
melanoma cell line compared with the other metastatic cell
line. Hence nm23 gene contain eight number of gene family
instead of nm23 e H1 is highly studied involving in cell pro-
liferation differentiation and development. Recent literature
were showed that the tumor cell behavior especially malig-
nant cell secretes some messenger compounds in which
attract neutrophil to activate protein kinase. It can degrade
the extracellular matrix leading to tumor metastasis.14,153. In-vitro antiproliferation mechanisms
The plant combination (muthu marunthu) has been showed
one of the common and notable features in poor growth rate
of tumor cells. Also the muthu marunthu is combination plant
biomass did not show any alteration of normal growing cells.
The glycoproteins such as hexose, hexosamine, sialic acid and
fucose are controlling the level in plasma by the treating of
muthu marunthu (different plant extracts were formulated in
various concentrations) fibrosarcoma rats. Hence muthu mar-
unthu has very good controlling capacity on the biochemical
events during tumor progression, without inducing any toxic
effects for normal metabolism.16 The aqueous extract of Ire-
sine herbstii was synthesized silver nanoparticles was per-
formed by green synthesis and plant mediated nanoparticles
showed potent cytotoxicity against HeLa cancer cells. Plant
synthesized silver nanoparticles have induced over above 80%
death of HeLa cell at a treatment of moderate concentration
level is 300 mg/ml. The AgNPs are revealed a prominent ac-
tivity of arrestmetabolic function of fibroblast cells (IMR-90) at
400 mg concentration.
The Persea americana Nigerian traditional plant extracts
were used for the treatment of anticancer studies. The plant
extracts contains polar compounds that were responsible for
suppress the division of cancer cells. Since it is well known
that the phytochemicals have been shown to induce cell cycle
which it may cause apoptosis program. The secondary me-
tabolites are affect the differentiation and proliferation of cells
by the control of intracellular (ROS) reactive oxygen species on
the electron transport chain and other metabolic pathway.
These cytotoxic natural products play a vital role in breast and
osteo cancer. The influences of anticancer activity were valid
by Elaeis guineensis methanol extract against MCF-7 and vera
cell line through by MTT assay. The presence of apoptotic
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cells. The cells are also showed extensive vacuolation in the
cytoplasm, indicating autophagy like mechanism of pro-
grammed cell death.174. In-vivo antiproliferation mechanisms
Sreelatha et al18 (2011) study demonstrates the ethanolic leaf
extract of Sesbania grandiflora has potential activity against
anticancer. The standard criteria of anticancer drug are sup-
press the protein synthesis metabolism as the same induces
apoptosis function of the cells. However the treatment of S.
grandiflora extracts were control the tumor cell volume and
number of viable tumor cell. The minimum dose of S. grandi-
flora 200 mg/kg have been exhibit high activity against leuke-
mia cells which may due to its extract and it contains nature
composite of various phytochemicals that could counter act
its toxicity.
Eucalyptus extract curiously decreased the tumor growth
rate and enhanced the life span of EAC behavior mice. The
development of normal transcriptional function of tumor
bearing mice has been considered as a very significant role of
EAC as anticancer drugs. The Eucalyptus extract treatment
group of animals were enhanced the production of macro-
phages in which stimulate other apoptosome molecules such
as tumor necrosis factor (TNF), interleukine (IL).19 Raihan
et al20 (2012) proved that the methanolic extract of Lager-
stroemia indica at its maximum dose 40 mg/kg can reduces the
growth of tumor adequately, as well as tumor weight and in-
crease the normal cell division function. Significantly cyto-
toxic activity shown by L. indica can be attributed mainly to
phenol, flavonoids and gallic acid. The mangostin fruit peri-
carp extracts has been exhibited the most effective for anti-
neoplastic mechanism through an induction of cell suicide
mechanism in tumor cells. Human colon cancer DLD-1 cells
was treated by mangostin extract it was exposed the anti-
proliferative effect of major xanthones. It was associated with
cell cycle, by affecting the expression of cdc2, cyclin kinases
and p27. The active form of xanthones called as a and b-
mangostins were to stimulate cell cycle arrest at the G1/G0
phase. In addition prenyl group of prenylated xanthone isTable 1 e Plant derived metabolites and its activity in differen
Plant name Materials Functional
compound
Cell line
Garcinia mangostana Pericarps Alpha mangostin Colon adenoca
NL-17
Impatiens textori Whole Crude compound Human cervica
cancer cell
Inula graveolens Whole Flavonoids, phenolics MCF-7
Inula viscosa Whole Inuviscolide, viscic
acid, xepetin
Human cervica
Ononis hirta Whole Crude compound HEp-2, MCF-7
Origanum majorana Leaves Crude compound Fibrosarcoma
Uncaria tomentosa Whole Alkaloids Human medul
carcinoma cellattributed to the cellular internalization, while leads to
interact with signal transduction molecules and proteins
involved in mitochondrial pathway.215. Plant derived secondary metabolites
control the proliferative cells
Plant derived chemical substances such as primary and sec-
ondary metabolites are involved in the anticancer mecha-
nisms especially control as well as prevent the abnormal
functions in cell division (Table 1). The mainly isolated
bioactive metabolites is vast such as alkaloid, flavonoids,
steroidal Saponin, enzymes and terpenoid are responsible for
the regulation of normal metabolic action of cells.22 Different
natural bioactive compounds used cancer therapeutics was
expressed in Fig. 1.
5.1. Flavonoids
5.1.1. Anthocyanins
Numerous flavonoids have been isolated from plant resources
as antitumor drugs. Anthocyanin the compound analog to
inhibit the cell growth in tumor cells including human lung
carcinoma and leukemia cell lines. The flavonoid derivative
analog derivatives are one of the important approaches for
cancer chemotherapy; that is to regulate cell-cycle progres-
sion. G1/S cell-cycle arrest was found in human hepatoma,
breast and colon carcinoma cells upon treatment of pigment
compound anthocyanidine.23 Flavones: Flavone 3-ols is a
synthetic derivative of the flavonoid compound with special
characteristics to treat of various cancers. The unique com-
pound induces the nitric oxide synthesis it may act as cellular
signaling for apoptosis mechanisms.24 Quercetin: The plant
derived Quercetin has been demonstrated in the action of cell
culture and in human DNA. The phase III trail in used to study
intraperitoneal doses of mice of quercetin has been found to
have antitumorogenic effect. However Quercetinwas found to
down regulate expression of p53 protein to nearly undetect-
able levels in human breast cancer cell lines.25 Cisplastin:
Cisplatin has established to be one of the efficient drugs for
cancer, because it targets the multiple intracellular sites, int cancer cell lines.
used Mode of assay Activity
rcinoma LDH cytotoxicity assay Retards the growth of
cancer cells
l/colon Cell viability assay Inhibit alpha glucosidases
Sulforhodamine B assay Antineoplastic mechanisms
l cancer MTT assay Exhibit the antiproliferation
function
cell line MTT assay Induction of apoptosis
(HT-180) MTT assay, fluorescence
microscopical study
Induces apoptosis
lary thyroid
s
Cell viability assay,
DAPI e stain
Reduction of proliferation
Fig. 1 e Recent clinical usage of plant derived anticancer agents.
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the efficiency of cisplatin functional analog, other drugs are
used for synthetic combination.26 Curcumin: Curcuma longa L.
the plants have long historical background which is not only
dietary supplement and also it contains more valuable ther-
apeutic compounds. Curcumin is a polyphenol compound act
as broad spectrum antibiotics including anticancer and anti-
inflammatory agent. The polyphenolic compound curcumin
inhibits proliferation of cancer cell line through regulating
numerous intracellular signaling pathways by secreting of
transcription factors (TF), growth factor receptors, cell surface
adhesion molecules and protein kinases. It is now under the
phase III trial in mainly by the treating of pancreatic cancer.
Apigenin: The apigenin phytochemical constituents mainly
induced cancer cell death is mediated by androgen receptor.
The prostate cancer cell line and breast cancer cell line was
chosen as study models because they both express only ERb.
The growth-inhibitory action of flavonoid based compound
apigenin on these cancer cell lineswas studied in the presence
or absence of small interfering RNA (siRNA) mediated down
regulation of the receptor.27
Pomiferin: Pomiferin is a prenylated isoflavonoid isolation
from the plantMaclura pomifera. Isoflavones have been shown
to possess a strong activity against anion exchange scav-
enging activity and also to inhibit the oxidative DNA damage.
Pomiferin has exposed pro-apoptotic effects by the results of
DNA fragmentation. The translational studies, it was shown
that pomiferin leads to down regulation of cytokeratins and to
express of known tumor related proteins. Harringtonine:
Harringtonine is chemical compound isolated from Chinese
medicinal plant Cephalotaxus harringtonia. Harringtonine
chemical entities have most promising activity against
leukemic cancer cell line. The alkaloid nature of thiscompound induces the apoptosis of cancer cells by inhibiting
protein synthesis at the ribosome level. Homoharringtonine
as a plant derived chemical compound under phase III clinical
trials for the treatment of patients with affected chronic
myeloid leukemia (CML). Salvicine: Salvicine used as the
antiproliferative effects by acting as a non-intercalative
topoisomerase II inhibitor that induces apoptosis. Salvicine
has entered phase II clinical trials for the treatment of solid
tumors in various ongoing researches.28
5.2. Polyphenols
Punicalagin: These punicalagin (plant: Punica granatum),
shows inhibition of DNA topoisomerase II in transcription
mechanisms. The chemical nature of punicalagin which is
contains an endocyclic a,b-unsaturated ketone group, it was
act more cytotoxic towards KB cells. Phenolic acids: The
phenolics are different compounds such as phenolic esters,
methyl derivatives and phenolic acids to use in various ther-
apeutic and commercial applications. Phenolic esters mainly
investigated for their antitumor activity in human adenocar-
cinoma cell line, also propyl and octyl gallates showed a more
effective activity against HeLa cells.29
5.3. Alkaloids
Campothecin: The alkaloid campothecin isolated from the
Chinese traditional plant Camptotheca acuminate. It is used in
the treatment of gastric, rectal, colon, and bladder cancers.
Their synthetic derivatives 9-aminocamptothecin, 10-
hydroxycamptothecin as well as camptothecin were vastly
used to treat various type of cancer.30 Vinca alkaloids
(vinblastine, vincristin): Isolated of two important anticancer
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Catharanthus roseus are well studied, these two natural alka-
loids are major use of drugs in the treatment of lymphoma
and leukemia respectively.31 Colchicine: The antimitotic
alkaloid colchicinewas isolated from Colchicum autumnale. The
plant has been traditionally treating of gout and fever. Recent
findings novel metabolites colchicine has revealed to control
the tubulin binding action. Indirubin: Indirubin is an antileu-
kemic compound isolated from the leaves of Indigofera tinctoria
which is mainly used in the treatment of chronic myelocytic
leukemia.325.4. Saponins
Diosgenin:Diosgenin is a steroidal saponin produced bymany
plants. The diosgenin, purified from the root of Polygonatum
zanlanscianense Pamp., that compound will leads to cell death
of tumor cells with moderate concentration. In cell culture
experiments with HeLa cervix carcinoma cells diosgenin
induced apoptosis in intrinsic pathway. It control the anti-
apoptotic protein Bcl-2 together with caspase activation was
observed. This compound was also isolated from rhizomes of
Smilacina atropurpurea. It stimulates the cytotoxicity on cancer
cells with minimal side effects.335.5. Terpenoids
Paclitaxel: Paclitaxel is a complex structure of diterpene iso-
lated from the bark of Taxus brevifolia. The cytotoxic activity of
Paclitaxel against mouse leukemia was well studied. It mainly
involved in cell cycle mechanisms for induces disruptions of
microtubule in tumor cells.33 Combrestatin A4: The Flava-
noids and its derivatives are also inhibit many enzymes thatFig. 2 e Structural analogues of importare the targets in anticancer treatment, e.g. eukaryotic DNA
topoisomerase I, Cox I and II and estrogen 2- and 4-hydroxy-
lases. Flavonoids by interacting with P450 enzymes reduce the
activation of procarcinogen substrates to carcinogens which
makes them anticancer substances in cancer therapy. Podo-
phyllotoxin: The plant derived podophyllotoxin is a bioactive
component of Podophyllum pelatum, and P. pleianthum. Its main
functions involved in mitotic cell division by binding revers-
ibly to tubulin and inhibiting microtubule assembly.345.6. Volatile oils
Thymoquinone: Thymoquinone (TQ) is the bioactive con-
stituent under the category of volatile oil. The compound is
isolated fromblack seed (Nigella sativa). TQ has been reported
to have potent anticancer and antioxidant abilities in both
animal models and cell culture systems. One of the most
favorable effects of TQ is that it exhibits high cancer speci-
ficity and low toxicity to normal cells. TQ has been highly
sensitivity to prostate cancer, colon cancer and skin cancer.
Many multidrug-resistant variants of human pancreatic
adenocarcinoma, uterine sarcoma, and leukemia were
found to be sensitive to TQ.35,36 The important anticancer
metabolites chemical structures were described in Figs. 2
and 3.6. Antioxidant vs proliferative cells
Antioxidants are compounds, enzymes or it may metals (non
enzymes) that involved in the system auto oxidation mecha-
nism by preventing the formation of free radicals.37 Oxidative
stress and reactive oxygen species (ROS) intermediated to cellant plant-based anticancer drugs.
Fig. 3 e Important secondary metabolites of plant-based anticancer drugs.
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human dangerous diseases such as certain cancers, neuro-
logical disorders, atherosclerosis and cardiovascular diseases.
At the biochemical mechanism of antioxidants in cellular
level cells are expose to oxidative stress which in turn causes
the highly affected in anabolic and catabolic pathways
including amino acid catabolism, protein oxidation, lipid
peroxidation, other cellular inner membrane disruption and
DNA damage.38,39 Plant derived antioxidant compounds can
activate the cellular signaling networks that stimulate the
normal cell division function that are observed in abnormal
cells. This includes phosphorylation process leading to the
activation of enzyme receptor switch on and off mechanisms,
kinase and phosphatase enzymes activities, induce the gene
expression level, inflammation and cancer. Oxidative regula-
tion in tumor cellsmay have a strongwave on the host system
to response against malignant deposit. The plant crude or
purified compounds have been highly potential activity in
cytoprotective and genoprotective effects against oxidative
stress and it control the free radical formation in electron
transport chain and other metabolic pathways.407. Plant mediated nanoparticle control the
tumor cells
The proper methods of immunization against tumor under-
standably have not yet found. But the revolution of nano-
pharmaceutics to synthesize the novel nanodrug carrier and
specific site of action has been high effect against malignancy
cells.41,42 Potentially prove the biosynthesized nanoparticles
as good effective drug materials for cancer. Particularly piperlongumine and piper longuminine act as capping agent for
synthesis of silver nanoparticles and it enhance the cytotoxic
effect on Hep-2 cell line. Piper longum plant synthesized
nanomaterials have significant cytotoxic effect (94%-500ug/
ml) against invasive cells.438. Pathway of cancer and genomic
expression
8.1. P53 gene expression
The P53 or TP53 tumor suppressor gene is the most frequently
changes gene in cancer. The p53 protein is a transcription
factor (TF) involved genome function by regulating cell death
mechanisms and progression of cell cycle. Accordingly mu-
tation of p53 is often difficult to treat and diagnosis is poor to
identity malignancy. The p53 tumor protein contain sequence
specific transcription factor, to stimulate cell growth arrest or
apoptosis. These cellular mechanisms is influenced by many
factors, including physical, chemical response, physiological
stress and the action of p53 co-factors, p53 induces wide
network of signals that act through two major apoptotic
pathways.44 They are intrinsic and extrinsic pathways.
8.2. Extrinsic pathway
The extrinsic apoptotic pathway (death receptor pathway)
generates to activation of a caspase reaction by caspase reg-
ulators. The death receptorsmechanism are involving various
member of receptor gene family such as tumor necrosis factor
(TNF), Fas R and Apo 3L. That molecules are stimulate the
Fig. 4 e The mechanism of apoptotic signaling pathways.
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ceptors are currently their therapeutic prospective of cancer,
including hematologic and hepatic malignancies. The signal
transduction of the extrinsic death receptor pathway involves
several caspases (family of cysteine proteases) which are
specific to cellular targets. Caspase is cascade mechanism,
once activated caspases stimulates several cellular function
as part of a process that called as programmed cell death/
death of the cells.458.3. Intrinsic pathway
The intrinsic pathway (mitochondrial) regulates the Bcl-2
family gene and BH evolutionary protein towards anti-
apoptotic mechanism, the formation of triggered by the cy-
tochrome c from the mitochondrion. The impact of the
apoptotic pathway may boost up the p53 target genes espe-
cially Bid, Bcl-5.The mainstream of the apoptotic mechanism
are mediated to stimulate the specific target gene in cell sui-
cide function.46,47 Conversely p53 can also stimulate apoptosis
cell suicide function by a post transcription mechanism in
which certain physiological conditions are met. Also these
tremendous functions of p53 constituents in apoptosis func-
tion may highly focused in cancer gene therapy.48 (Fig. 4).9. Conclusion
The cancer and its mechanisms to induce the apoptotic cell
function are vast studied. Hence different plant and secondary
metabolites involved in the stimulate the cell suicide func-
tions. Recently, the molecular drug development to cancer
drug analog has facilitated and well designed for targeted site
action in cancer therapies. The newly emerged development
of the molecular characterization of cancer studies andevolution to makes it promising to develop more effective
plant based drugs, and also technical supportive to moni-
toring the cancer cells pathway. The plant derived anticancer
agents are mainly controlled the various cell mechanism in
different stages of cancer such as:
i) methyl transferase inhibitors
ii) mitotic disruptors
iii) DNA damage or pro antioxidant drugs
iv) HDAC inhibitors (HDACi)
v) inhibit the topoisomerase II action and so on.10. Summary
The abundant results and ethnobotanical evidence suggests
that plant and its compounds have beneficial effects against
various cancers. Antineoplastic potential of phytochemicals
that it is partially mediated through their ability to neutralize
the body functions and also repair DNA damage, subsequent
control the free radicals formation. There is now a great
conscious in the developing of plant based drugs to against
cancer and related diseases. Hence those kind of natural
materials repair the cell damage and induce the normal
metabolic function of the cells. Recently the great interests to
developing novel plant purified product have been triggering
the apoptotic program. The common impacts of tumors have
defects in the p53 pathway and many overexpresses of
different proteins such as Bcl-2, Box and BH3 or their close
relative enzymes. According to the cluster mechanisms of
apoptotic machinery remains fail to function in cell death
clock. Especially, the plant derived drug that could have bind
to the pro-survival protein by in which controls the cancer
cells and inactivate further protein synthesis mechanisms.
Nowadays cancer prospects are upbeat for the findings the
mechanisms of tumor and novel drug analog for cancer and
j o u r n a l o f p h a rm a c y r e s e a r c h 6 ( 2 0 1 3 ) 8 8 4e8 9 2 891treatments. Cancer treatment and preventing methodologies
are still challenge for traditional conceptions of disease.
Likewise the demanding to the development modern plant
derived anticancer compound is more important for cancer
control. The broad containment strategy for cancer might
target all stages of disease progression. Effort to exploit on the
emerging prospects of plant derived drug to treat cancer will
profit significant benefits for patients as well as to those
engaged in the field of drug development.Conflict of interest
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